Interwest Partners X Lp - Jun 28, 2021 Form 4 Insider Report for Doximity, Inc. (DOCS)

Role
10%+ Owner
Signature
/s/ Karen A. Wilson, Attorney-in-Fact for InterWest Partners X, L.P.
Stock symbol
DOCS
Transactions as of
Jun 28, 2021
Transactions value $
-$105,386,873
Form type
4
Date filed
6/28/2021, 06:18 PM
Previous filing
Jun 23, 2021
Next filing
Jul 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DOCS Class A Common Stock Conversion of derivative security +4.29M 4.29M Jun 28, 2021 Direct F1, F2
transaction DOCS Class A Common Stock Sale -$105M -4.29M -100% $24.57 0 Jun 28, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DOCS Series A Preferred Stock Conversion of derivative security $0 -13.3M -100% $0.00* 0 Jun 28, 2021 Class B Common Stock 13.3M Direct F2, F4, F5
transaction DOCS Series B Preferred Stock Conversion of derivative security $0 -5.41M -100% $0.00* 0 Jun 28, 2021 Class B Common Stock 5.41M Direct F2, F4, F5
transaction DOCS Series C Preferred Stock Conversion of derivative security $0 -2.74M -100% $0.00* 0 Jun 28, 2021 Class B Common Stock 2.74M Direct F2, F4, F5
transaction DOCS Class B Common Stock Conversion of derivative security $0 +21.4M $0.00 21.4M Jun 28, 2021 Class A Common Stock 21.4M Direct F2, F4, F5
transaction DOCS Class B Common Stock Conversion of derivative security $0 -4.29M -20% $0.00 17.2M Jun 28, 2021 Class A Common Stock 4.29M Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.
F2 These shares are directly held by InterWest Partners X, L.P. ("InterWest"). InterWest Management Partners X, LLC ("IMP X") is the general partner of InterWest. Gilbert H. Kliman is the Managing Director of IMP X. Keval Desai and Khaled Nasr are Venture Members of IMP X. Each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr may be deemed to beneficially own the shares held by InterWest, and each of IMP X, Gilbert H. Kliman, Keval Desai and Khaled Nasr disclaims beneficial ownership of such shares, except to the extent of its or his pecuniary interest therein.
F3 These shares were sold by InterWest in connection with the Issuer's initial public offering ("IPO") at a net price per share of $24.57 (after underwriting discounts and commissions). InterWest was a selling stockholder in the IPO.
F4 Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into one share of Class B Common Stock on a one-for-one basis, immediately prior to the closing of the IPO. The shares of Preferred Stock have no expiration date.
F5 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the IPO; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

Remarks:

Gilbert H. Kliman, a Managing Director of IMP X, is also a Director of the Issuer and has filed a separate Form 4 in his own name.